Risk of dyslipidaemia in people living with HIV who are taking tenofovir alafenamide: a systematic review and meta-analysis.
Jeong-Ju YooEun Ae JungSang Gyune KimYoung Seok KimMin Jae KimPublished in: Journal of the International AIDS Society (2024)
Tenofovir alafenamide use in people living with HIV is associated with significant alterations in lipid profile.
Keyphrases